We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > gabapentin

News List

FDA Releases New Drug Safety Communication on Gabapentin, Pregabalin americanpharmaceuticalreview
December 23, 2019
The U.S. Food and Drug Administration (FDA) is warning that serious breathing difficulties may occur in patients using gabapentin (Neurontin, Gralise, Horizant) or pregabalin (Lyrica, Lyrica CR) ...
Gabapentin, Opioids a Deadly Duo: FDA drugs
December 20, 2019
New warnings about the risk of dangerous breathing difficulties when gabapentinoids are used with opioids or by certain patients must now appear on product labels ...
More money, more gabapentin worldpharmanews
July 10, 2019
Pharmaceutical companies' payments to doctors may be influencing them to prescribe more expensive, brand-name versions of the pain drug gabapentin...
Gabapentin Improves Sexual Function in Provoked Vulvodynia drugs
January 08, 2019
For women with provoked vulvodynia, gabapentin improves sexual function compared with placebo, although overall sexual function is still lower than for pain-free controls.....